MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors
Source: SeekingAlpha
2026-01-02 08:42:10 ET
More on MeiraGTx
- MeiraGTx Holdings plc (MGTX) Presents at Evercore 8th Annual Healthcare Conference Transcript
- MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential
- Eli Lilly in pact with MeiraGTx to develop gene therapies for eye diseases
- Seeking Alpha’s Quant Rating on MeiraGTx
- Historical earnings data for MeiraGTx
Read the full article on Seeking Alpha
For further details see:
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors
MeiraGTx Holdings plc
NASDAQ: MGTX
MGTX Trading
0.81% G/L:
$6.88 Last:
146,785 Volume:
$6.81 Open:
MGTX Latest News
February 17, 2026 09:05:00 am
Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A
February 03, 2026 08:00:00 am
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy
November 20, 2025 03:00:00 pm
Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference
MGTX Stock Data
$607,706,212
74,454,072
4.21%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
New York
